Background: Ulcerative colitis (UC) is a debilitating chronic inflammation with frequent relapses. Fecal calprotectin (FCP), a cytosolic protein of mucosal neutrophils, is the most promising non-invasive fecal marker of intestinal inflammation. We have previously shown that UC patients in clinical remission who had FCP>150 µg/g had a significantly higher chance of relapse within the next 12 months. Aims: In this study we aimed to investigate which demographic, clinical, laboratory, dietary and lifestyle related factors were associated with high FCP.
